Abbott Historical Income Statement
ABT Stock | USD 105.27 0.63 0.59% |
Historical analysis of Abbott Laboratories income statement accounts such as Interest Expense of 605.1 M, Selling General Administrative of 6.2 B or Total Revenue of 22.2 B can show how well Abbott Laboratories performed in making a profits. Evaluating Abbott Laboratories income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Abbott Laboratories's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Abbott Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Abbott Laboratories is a good buy for the upcoming year.
Abbott |
About Abbott Income Statement Analysis
Abbott Laboratories Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Abbott Laboratories shareholders. The income statement also shows Abbott investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Abbott Laboratories Income Statement Chart
Abbott Laboratories Income Statement is one of the three primary financial statements used for reporting Abbott's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Abbott Laboratories revenue and expense. Abbott Laboratories Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Abbott Laboratories' Depreciation And Amortization is comparatively stable compared to the past year. EBITDA is likely to gain to about 11.1 B in 2024, whereas Total Revenue is likely to drop slightly above 22.2 B in 2024. Add Fundamental
Total Revenue
Total revenue comprises all receipts Abbott Laboratories generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Abbott Laboratories minus its cost of goods sold. It is profit before Abbott Laboratories operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Abbott Laboratories. It is also known as Abbott Laboratories overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Abbott Laboratories' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Abbott Laboratories current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.At this time, Abbott Laboratories' Depreciation And Amortization is comparatively stable compared to the past year. EBITDA is likely to gain to about 11.1 B in 2024, whereas Total Revenue is likely to drop slightly above 22.2 B in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 24.5B | 24.5B | 22.1B | 12.5B | Total Revenue | 43.1B | 43.7B | 40.1B | 22.2B |
Abbott Laboratories income statement Correlations
Click cells to compare fundamentals
Abbott Laboratories Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Abbott Laboratories income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Depreciation And Amortization | 2.1B | 2.2B | 2.3B | 2.3B | 3.2B | 3.4B | |
Interest Expense | 576M | 500M | 490M | 375M | 637M | 605.2M | |
Selling General Administrative | 9.8B | 9.7B | 11.3B | 11.0B | 11.2B | 6.2B | |
Total Revenue | 31.9B | 34.6B | 43.1B | 43.7B | 40.1B | 22.2B | |
Gross Profit | 18.7B | 19.6B | 24.5B | 24.5B | 22.1B | 12.5B | |
Other Operating Expenses | 27.4B | 29.3B | 34.7B | 35.3B | 33.6B | 18.2B | |
Operating Income | 4.5B | 5.4B | 8.4B | 8.4B | 6.5B | 3.8B | |
Ebit | 4.5B | 5.4B | 8.4B | 8.4B | 7.3B | 3.7B | |
Ebitda | 6.7B | 7.6B | 10.7B | 10.7B | 10.6B | 11.1B | |
Cost Of Revenue | 13.2B | 15.0B | 18.5B | 19.1B | 18.0B | 9.6B | |
Total Operating Expenses | 14.1B | 14.2B | 16.1B | 16.1B | 15.7B | 8.6B | |
Income Before Tax | 4.1B | 5.0B | 8.2B | 8.3B | 6.7B | 3.8B | |
Total Other Income Expense Net | (56M) | (455M) | (389M) | (214M) | 438M | 459.9M | |
Net Income | 3.7B | 4.5B | 7.1B | 6.9B | 5.7B | 3.1B | |
Income Tax Expense | 390M | 497M | 1.1B | 1.4B | 941M | 792.1M | |
Research Development | 2.4B | 2.4B | 2.7B | 2.9B | 2.7B | 2.3B | |
Net Income Applicable To Common Shares | 3.7B | 4.5B | 7.1B | 6.9B | 8.0B | 8.4B | |
Minority Interest | 201M | 198M | 213M | 219M | 251.9M | 264.4M | |
Net Income From Continuing Ops | 3.7B | 4.5B | 7.1B | 6.9B | 5.2B | 4.3B | |
Non Operating Income Net Other | 215M | 157M | 319M | 502M | 577.3M | 606.2M | |
Tax Provision | 390M | 497M | 1.1B | 1.4B | 1.0B | 949.8M | |
Interest Income | 94M | 492M | 491M | 377M | 384M | 269.0M | |
Net Interest Income | (576M) | (500M) | (490M) | (375M) | (248M) | (260.4M) | |
Reconciled Depreciation | 3.0B | 3.3B | 2.0B | 2.0B | 3.2B | 2.3B |
Abbott Laboratories Investors Sentiment
The influence of Abbott Laboratories' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Abbott. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Abbott Laboratories' public news can be used to forecast risks associated with an investment in Abbott. The trend in average sentiment can be used to explain how an investor holding Abbott can time the market purely based on public headlines and social activities around Abbott Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Abbott Laboratories' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Abbott Laboratories' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Abbott Laboratories' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Abbott Laboratories.
Abbott Laboratories Implied Volatility | 59.19 |
Abbott Laboratories' implied volatility exposes the market's sentiment of Abbott Laboratories stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Abbott Laboratories' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Abbott Laboratories stock will not fluctuate a lot when Abbott Laboratories' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Abbott Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Abbott Laboratories' short interest history, or implied volatility extrapolated from Abbott Laboratories options trading.
Pair Trading with Abbott Laboratories
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.Moving against Abbott Stock
0.44 | GCTK | GlucoTrack | PairCorr |
0.43 | WST | West Pharmaceutical Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.
The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Abbott Stock analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Dividend Share 2.12 | Earnings Share 3.21 | Revenue Per Share 23.183 | Quarterly Revenue Growth 0.022 |
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.